Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER studyYuankai Shi, Xiaohong Han, Junling Li et al.|PLoS ONE|2015Cited by 206
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)Yuankai Shi, Yu Huang, Yan Sun et al.|Asia-Pacific Journal of Clinical Oncology|2016Cited by 44
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).Yuankai Shi, Fenlai Tan, Lin Wang et al.|Journal of Clinical Oncology|2016Cited by 14
Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy.Caicun Zhou, Jielai Xia, Changping Wu et al.|Journal of Clinical Oncology|2014Cited by 0